Growth Metrics

Glaukos (GKOS) EBIT (2016 - 2025)

Glaukos (GKOS) has disclosed EBIT for 12 consecutive years, with -$139.9 million as the latest value for Q4 2025.

  • Quarterly EBIT fell 321.58% to -$139.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$199.6 million through Dec 2025, down 552.76% year-over-year, with the annual reading at -$199.6 million for FY2025, 552.76% down from the prior year.
  • EBIT for Q4 2025 was -$139.9 million at Glaukos, down from -$16.4 million in the prior quarter.
  • The five-year high for EBIT was $63.1 million in Q4 2024, with the low at -$139.9 million in Q4 2025.
  • Average EBIT over 5 years is -$18.7 million, with a median of -$22.2 million recorded in 2022.
  • Peak annual rise in EBIT hit 283.78% in 2023, while the deepest fall reached 436.94% in 2023.
  • Over 5 years, EBIT stood at -$17.9 million in 2021, then crashed by 88.79% to -$33.7 million in 2022, then surged by 283.78% to $62.0 million in 2023, then rose by 1.82% to $63.1 million in 2024, then tumbled by 321.58% to -$139.9 million in 2025.
  • According to Business Quant data, EBIT over the past three periods came in at -$139.9 million, -$16.4 million, and -$22.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.